Device-Assisted Exercise for Spinal Cord Injury
Trial Summary
What is the purpose of this trial?
This study aims to determine the effects of transcutaneous spinal cord stimulation to increase blood pressure and use that device to increase exercise endurance time and heart rate recovery during arm cycle ergometry. In addition, the investigators will see if the stimulation helps regulate body temperature when in a cool environment.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it requires that your medication regimen has been stable for at least 30 days before joining.
What data supports the effectiveness of the treatment DS8R Biphasic Constant Current Stimulator for spinal cord injury?
Research on similar treatments, like functional electrical stimulation (FES), shows that electrical stimulation can improve muscle strength, walking speed, and bone health in people with spinal cord injuries. For example, one study found that FES increased walking speed by nearly 50% over a year, and another reported significant improvements in walking distance and speed after 12 weeks of training with an implanted FES system.12345
Is device-assisted exercise using functional electrical stimulation safe for people with spinal cord injuries?
How is the DS8R treatment different from other treatments for spinal cord injury?
The DS8R treatment is unique because it uses a biphasic constant current stimulator to assist exercise, which may enhance muscle activation and improve mobility in spinal cord injury patients. This approach is different from other treatments that often rely on functional electrical stimulation (FES) systems, which are typically used for gait training and require implanted or external devices to stimulate specific muscles.234510
Research Team
Jill M Wecht, EdD
Principal Investigator
James J. Peters Veterans Affairs Medical Center
Eligibility Criteria
This trial is for individuals with a spinal cord injury at levels C3-T1, classified as AIS A or B, who are non-ambulatory and have had their injury for over a year. Participants must be on stable medications for 30 days and commit to 7 visits in 60 days. It's not suitable for those with recent seizures, psychological disorders, substance abuse, open skin lesions on the spine, ventilator dependence, other neurological disorders or head trauma.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Determining baseline autonomic function and screening for hypotension and orthostatic hypotension
Stimulation Parameter Determination
Determine optimal stimulation site on the spine (T7-T8 or T11-12) to increase seated systolic blood pressure
Treatment
Participants undergo submaximal arm ergometry exercise with optimal electrode placement and a sham visit
Temperature Regulation Assessment
Assess core temperature in a cool environment with stimulator on and off
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- DS8R (Spinal Cord Stimulation)
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor
Dr. Grant Huang
VA Office of Research and Development
Acting Chief Research and Development Officer
PhD in Medical Psychology and Master of Public Health from the Uniformed Services University of Health Sciences
Dr. Erica M. Scavella
VA Office of Research and Development
Chief Medical Officer since 2022
MD from University of Massachusetts School of Medicine